欧盟 - 葡萄牙文 - EMA (European Medicines Agency)

eli lilly nederland b.v. - insulina lispro - diabetes mellitus - drogas usadas em diabetes - para o tratamento de adultos e crianças com diabetes mellitus que necessitam de insulina para a manutenção da homeostase normal da glicose. liprolog também é indicado para a estabilização inicial do diabetes mellitus.

欧盟 - 葡萄牙文 - EMA (European Medicines Agency)

eli lilly and company (ireland) limited - ixekizumab - psoríase - imunossupressores - placa psoriasistaltz é indicado para o tratamento de moderada para severa psoríase em placas em adultos que são candidatos à terapia sistêmica,. psoriática arthritistaltz, sozinho ou em combinação com metotrexato, é indicado para o tratamento da artrite psoriática activa em pacientes adultos que responderam inadequadamente, ou que são intolerantes a um ou mais doenças anti-reumáticas de drogas (dmcd) terapias.

欧盟 - 葡萄牙文 - EMA (European Medicines Agency)

eli lilly nederland b.v. - baricitinib - artrite, reumatóide - imunossupressores - rheumatoid arthritisbaricitinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). olumiant pode ser usado como monoterapia ou em combinação com metotrexato. atopic dermatitisolumiant is indicated for the treatment of moderate to severe atopic dermatitis in adult and paediatric patients 2 years of age and older who are candidates for systemic therapy. alopecia areatabaricitinib is indicated for the treatment of severe alopecia areata in adult patients (see section 5. juvenile idiopathic arthritisbaricitinib is indicated for the treatment of active juvenile idiopathic arthritis in patients 2 years of age and older who have had an inadequate response or intolerance to one or more prior conventional synthetic or biologic dmards:- polyarticular juvenile idiopathic arthritis (polyarticular rheumatoid factor positive [rf+] or negative [rf-], extended oligoarticular),- enthesitis related arthritis, and- juvenile psoriatic arthritis. baricitinib may be used as monotherapy or in combination with methotrexate.

欧盟 - 葡萄牙文 - EMA (European Medicines Agency)

eli lilly nederland b.v. - abemaciclib - neoplasias do peito - agentes antineoplásicos - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.

欧盟 - 葡萄牙文 - EMA (European Medicines Agency)

eli lilly nederland b.v. - glucagon - diabetes mellitus - pâncreas hormônios, hormônios glycogenolytic - baqsimi é indicado para o tratamento de hipoglicemia grave em adultos, adolescentes e crianças com idade entre 4 e mais anos com diabetes mellitus.

欧盟 - 葡萄牙文 - EMA (European Medicines Agency)

eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - agentes antineoplásicos - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.

欧盟 - 葡萄牙文 - EMA (European Medicines Agency)

eli lilly nederland b.v. - lasmiditan succinate - transtornos da enxaqueca - analgésicos - rayvow is indicated for the acute treatment of the headache phase of migraine attacks, with or without aura in adults.

欧盟 - 葡萄牙文 - EMA (European Medicines Agency)

eli lilly nederland b.v. - pirtobrutinib - linfoma, mantle-cell - inibidores de proteína quinase - treatment of mantle cell lymphoma (mcl).

葡萄牙 - 葡萄牙文 - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

baldacci - portugal, s.a. - valsartan + hidroclorotiazida - comprimido revestido por película - 160 mg + 12.5 mg - valsartan 160 mg ; hidroclorotiazida 12.5 mg - valsartan and diuretics - genérico - duração do tratamento: longa duração

葡萄牙 - 葡萄牙文 - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

farmoz - sociedade técnico medicinal, s.a. - valsartan + hidroclorotiazida - comprimido revestido por película - 160 mg + 25 mg - valsartan 160 mg ; hidroclorotiazida 25 mg - valsartan and diuretics - genérico - duração do tratamento: longa duração